Overview
Mark Cowley practices in Sydney, Australia. Mr. Cowley is rated as an Experienced expert by MediFind in the treatment of Microcephaly Deafness Syndrome. His top areas of expertise are Pancreatic Cancer, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Embryonal Tumor with Multilayered Rosettes, and Islet Cell Transplantation.
His clinical research consists of co-authoring 160 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Microcephaly Deafness Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Autosomal Dominant Polycystic Kidney Disease
- Pancreatic CancerMr. Cowley isAdvanced. Learn about Pancreatic Cancer.
- Polycystic Kidney DiseaseMr. Cowley isAdvanced. Learn about Polycystic Kidney Disease.
- Experienced
- Achalasia Microcephaly SyndromeMr. Cowley isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Acrofacial Dysostosis Rodriguez TypeMr. Cowley isExperienced. Learn about Acrofacial Dysostosis Rodriguez Type.
- Acrofrontofacionasal Dysostosis Syndrome
- Acromicric DysplasiaMr. Cowley isExperienced. Learn about Acromicric Dysplasia.
- Acute Cerebellar AtaxiaMr. Cowley isExperienced. Learn about Acute Cerebellar Ataxia.
- Acute Lymphoblastic Leukemia (ALL)Mr. Cowley isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).